(CLXT) – PRNewswire
-
Calyxt Announces Stockholder Approval of Merger With Cibus
-
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Calyxt Completes One-for-Ten Reverse Stock Split
-
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
-
Calyxt Announces Effective Date of Reverse Stock Split
-
Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update
-
Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
-
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company
-
Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil
-
Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
-
Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing
-
Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time
-
Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants
-
Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients
-
Calyxt, Inc. Exploring Strategic Alternatives
-
Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference
-
Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference
-
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
-
Calyxt to Present at Upcoming Conferences
-
Calyxt Reports First Quarter 2022 Financial Results
-
Calyxt Announces Strategic Hires in Business Development and Manufacturing
-
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
-
Calyxt to Participate in Fireside Chat at the 34th Annual Roth Conference
-
Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results
-
Calyxt to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time
-
Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock
-
Calxyt, Inc. Announces Pricing of $10.9 Million SEC-Registered Offering of Common Stock and Warrants
-
Calyxt Announces Gerry Nuovo as Senior Vice President of Business Development
-
Calyxt Announces Pilot BioFactory™ Production System Now Operational
-
Calyxt to Present at the H.C. Wainwright BioConnect Virtual Conference
-
Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run
-
Calyxt Announces Strategic Hires in AI/ML and Technology Licensing
-
Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum
-
Calyxt Reports Third Quarter 2021 Financial Results
-
Calyxt to Host third Quarter 2021 Financial Results Conference Call on Thursday, November 4, 2021, at 4:30 p.m. Eastern Time
-
Calyxt Names IBM's Global Chief Artificial Intelligence Officer, Dr. Seth Dobrin, to Scientific Advisory Board
-
Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers
-
Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative
-
Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference
-
Calyxt Reports Second Quarter 2021 Financial Results
-
Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021
-
Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
-
Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time
-
Calyxt Appoints Michael A. Carr as Chief Executive Officer
-
S&W Seed Company Provides Seed Trait Technology Development and Commercialization Update
-
S&W Seed Company Announces Commercial Agreement with Calyxt Inc. to Deliver Improved Quality Alfalfa
Back to CLXT Stock Lookup
